Alphatec had the best second quarter, with a 35 percent increase in revenue, while Conformis, which saw its revenue fall 73 percent compared to last year, had the worst.
14 orthopedic and spine company revenues for Q2:
1. ZimVie: $233.4 million
2. Surgalign: $20.6 million
3. Conformis: $15.3 million
4. Alphatec: $84 million
5. Orthofix: $118.1 million
6. Enovis: $395 million
7. Paragon: $36.8 million
8. NuVasive: $310.5 million
9. SeaSpine: $56.3 million
10. Zimmer Biomet: $1.8 billion
11. Smith + Nephew: $1.3 billion
12. Stryker: $4.5 billion
13. Johnson & Johnson: $2.2 billion
14. Implanet: $2.1 million
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
